New Drug Kills Cancer 20,000x More Effectively With No Detectable Side Effects

Cancer drug made 20,000 times more potent in breakthrough

Tested in animal models of acute myeloid leukemia, the new nanomedicine was dramatically more effective while also less toxic.

New Drug Kills Cancer 20,000x More Effectively With No Detectable Side Effects

By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned the molecular structure of a well-known chemotherapy drug, greatly increasing its solubility, effectiveness, and safety. For this study, the scientists created the drug entirely from scratch as a [...]

New nanodrug is 20,000x more lethal to leukemia while sparing healthy cells

Cancer treatment has always been a balancing act—hit the tumor hard enough to kill it, but not so hard that the patient breaks first. For decades, chemotherapy has walked that razor’s edge, saving lives but leaving patients weak, nauseated, and scared to face the next round. Now, a team at Northwestern University thinks they’ve found a way to tip that balance toward healing. Led by chemist Chad A. Mirkin, the researchers have re-engineered one o…

New nanomedicine wipes out leukemia in animal study

Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic.

Nanomedicine Breakthrough Redefines Oncology Drug Delivery - Mpelembe Network

This report focuses on a major shift in the oncology market toward advanced drug delivery systems, specifically nanomedicine. It highlights how poor bioavailability limits the effectiveness of traditional cancer drugs and presents Oncotelic Therapeutics Inc.’s Deciparticle platform as a solution designed to significantly increase drug absorption and reduce toxicity. The article details the platform’s versatility, its clinical momentum with the a…